Listen Now
Topics Covered
- Overview of Blood Cancers, in the Context of COVID-19
- New Research Presented at ASH
- Disease-Specific Treatment Updates from ASH on Leukemia, Lymphoma, Multiple Myeloma and Myeloproliferative Neoplasms (MPN)
- The Role of Precision Medicine & Clinical Trials
- Talking with Your Health Care Team about Your Treatment Options
- Communicating with Your Health Care Team with Telehealth/Telemedicine Appointments
- Guidelines to Prepare for These Appointments
- Key Questions to Ask Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts

Peter Martin, MD, MS
Chief, Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian/Weill Cornell Medical Center

Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

William I. Bensinger, MD
Myeloma & Transplant Program, Swedish Cancer Institute

Ruben A. Mesa, MD, FACP
Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, UT Health San Antonio Cancer Center – An NCI Designated Cancer Center

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on December 10, 2020.